ClinicalTrials.gov
public full text
Public Domain
An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive Disorder
The main purpose of this study is to evaluate the efficacy of saredutant 100mg once daily in combination with escitalopram 10mg once daily compared to saredutant placebo in combination with escitalopram 10mg once daily in patients with major depressive disorder. This study also includes a double-placebo group (saredutant placebo in combination with escitalopram placebo).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to Escitalopram#855521
- SSRI and Buprenorphine#903918
- Sertraline Versus Escitalopram in South Asian Participants With Moderate to Severe Major Depressive Disorder#906923
- Escitalopram as a Mood Stabilizer for Bipolar II Disorder#800244
- Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months#834860
Record · ID 1074428
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive